Lymphoma Hub | Quarter Two 2020 Update

It has been an exciting and busy few months for the Lymphoma Hub covering the key new data presented at various congresses. While COVID-19 has made this a very challenging year for congresses, the Lymphoma Hub was pleased to be able to virtually cover the American Association for Cancer Research (AACR) meeting. During this congress, we produced podcasts, video interviews with experts, and written summaries from the sessions. The Lymphoma Hub also provided live coverage of the virtual American Society of Clinical Oncology (ASCO) Annual Meeting, and the virtual European Hematology Association (EHA) Annual Congress (EHA25 Virtual) via our Twitter channel. We also conducted interviews with experts and are continuing to publish summary articles of key sessions and podcasts.

At the beginning of the year the Lymphoma Hub launched its new, redesigned website. As a new feature, the Lymphoma Hub has now launched a podcast channel. Podcasts are available on Apple Podcast, Spotify, and all other major podcast apps to listen to and download.

In May, the Lymphoma Hub introduced a new educational theme of 'Advances in T-cell lymphomas'. The main introductory article broaches the subject and summarizes some of the latest advances and key clinical trials in T-cell lymphoma. The aim of the education themes on the Lymphoma Hub is to expand the information available on key topics in lymphoma.

On May 18, the Lymphoma Hub held a virtual Steering Committee (SC) meeting. Scientific Education Support (SES) presented the recent highlights and achievements of the Lymphoma Hub, including delivering a multi-sponsored satellite symposium at the International Conference on Malignant Lymphoma (ICML) in 2019, improving all metrics on the website and social media, and continuing to be a top social media influencer at all major congresses. The SC provided guidance and insights on relevant topics and current challenges in lymphoma and chronic lymphocytic leukemia (CLL), as well as suggestions on how to address the current unmet educational needs.

We regret to announce that Professor Anas Younes is stepping down from the Lymphoma Hub. We would like to thank him for all his hard work and contributions as Co-Chair of the Lymphoma Hub and wish him all the best!

In other SC member news, we would like to congratulate the Lymphoma Hub Chair, Professor Gilles Salles, on his upcoming move to the Memorial Sloan Kettering Cancer Center. In addition to this, we would like to extend our congratulations to Gilles on winning the EHA José Carreras Lecture Award 2020. The José Carreras Lecture Award was established to honor leaders in hematological research and is presented each year to an established and active investigator who has made an important contribution to hematology.

The Lymphoma Hub, founded in partnership with the European Lymphoma Institute (ELI) and brought to you by SES, is dedicated to providing up-to-date, unbiased material for healthcare professionals. The Lymphoma Hub remains forever grateful to our ongoing supporters – Celgene (Platinum), AstraZeneca (Silver), Gilead (Silver), Novartis (Silver), Nordic Nanovector (Bronze), Roche (Bronze), Epizyme (Contributor) and Karyopharm Therapeutics (Contributor).

For more information on the Lymphoma Hub, please visit www.lymphomahub.com. For media enquiries, or to explore collaboration opportunities, please contact secretariat@scientificeducationsupport.com.